{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T09:26:55Z","timestamp":1781256415019,"version":"3.54.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.ymgme.2012.01.010","type":"journal-article","created":{"date-parts":[[2012,1,19]],"date-time":"2012-01-19T08:29:00Z","timestamp":1326961740000},"page":"615-620","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Fabry disease: Biochemical, pathological and structural studies of the \u03b1-galactosidase A with E66Q amino acid substitution"],"prefix":"10.1016","volume":"105","author":[{"given":"Tadayasu","family":"Togawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Tsukimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Kodama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshie","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikuo","family":"Kawashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuki","family":"Ohno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Fukushige","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuro","family":"Kanekura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Satomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duk-Hee","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beom Hee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Wook","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kent","family":"Doi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eisei","family":"Noiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Sakuraba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2012.01.010_bb0005","series-title":"The Metabolic and Molecular Bases of Inherited Disease","first-page":"3733","article-title":"\u03b1-Galactosidase A deficiency: Fabry disease","author":"Desnick","year":"2001"},{"key":"10.1016\/j.ymgme.2012.01.010_bb0010","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1161\/CIRCULATIONAHA.108.794529","article-title":"Long-term effects of enzyme replacement therapy on Fabry cardiomyopathy: evidence for a better outcome with early treatment","volume":"119","author":"Weidemann","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.ymgme.2012.01.010_bb0015","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/ndt\/gfi152","article-title":"Long-term therapy with agalsidase alfa for Fabry disease: safety and effects on renal function in a home infusion setting","volume":"21","author":"Schiffmann","year":"2006","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.ymgme.2012.01.010_bb0020","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1086\/504601","article-title":"High incidence of later-onset Fabry disease revealed by newborn screening","volume":"79","author":"Spada","year":"2006","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2012.01.010_bb0025","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1002\/humu.21074","article-title":"Newborn screening for Fabry disease in Taiwan reveals a high incidence of the later-onset GLA mutation c.936+919G>A (IVS4+919G>A)","volume":"30","author":"Hwu","year":"2009","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgme.2012.01.010_bb0030","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/s10157-005-0369-4","article-title":"Significance of screening for Fabry disease among male dialysis patients","volume":"9","author":"Ichinose","year":"2005","journal-title":"Clin. Exp. Nephrol."},{"key":"10.1016\/j.ymgme.2012.01.010_bb0035","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2215\/CJN.02490607","article-title":"Screening for Fabry disease in patients with chronic kidney disease: limitations of plasma alpha-galactosidase assay as a screening test","volume":"3","author":"Andrade","year":"2008","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ymgme.2012.01.010_bb0040","doi-asserted-by":"crossref","first-page":"281","DOI":"10.5414\/CNP64281","article-title":"Identification of Fabry's disease by the screening of alpha-galactosidase A activity in male and female hemodialysis patients","volume":"64","author":"Tanaka","year":"2005","journal-title":"Clin. Nephrol."},{"key":"10.1016\/j.ymgme.2012.01.010_bb0045","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1046\/j.1523-1755.2003.00160.x","article-title":"Fabry disease: detection of undiagnosed hemodialysis patients and identification of a \u201crenal variant\u201d phenotype","volume":"64","author":"Nakao","year":"2003","journal-title":"Kidney Int."},{"key":"10.1016\/j.ymgme.2012.01.010_bb0050","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/humu.9520","article-title":"Novel mutations of the GLA gene in Japanese patients with Fabry disease and their functional characterization by active site specific chaperone","volume":"29","author":"Shimotori","year":"2008","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgme.2012.01.010_bb0055","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0002-9149(00)01275-3","article-title":"Molecular genetic, biochemical, and clinical studies in three families with cardiac Fabry's disease","volume":"87","author":"Yoshitama","year":"2001","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ymgme.2012.01.010_bb0060","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/jhg.2010.58","article-title":"Mutations of the GLA gene in Korean patients with Fabry disease and frequency of the E66Q allele as a functional variant in Korean newborns","volume":"55","author":"Lee","year":"2010","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2012.01.010_bb0065","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0009-8981(81)90384-3","article-title":"Differential assay for lysosomal alpha-galactosidases in human tissues and its application to Fabry's disease","volume":"112","author":"Mayes","year":"1981","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ymgme.2012.01.010_bb0070","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ymgme.2010.03.020","article-title":"Plasma globotriaosylsphingosine as a biomarker of Fabry disease","volume":"100","author":"Togawa","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2012.01.010_bb0075","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.ajhg.2009.09.016","article-title":"Use of a modified alpha-N-acetylgalactosaminidase in the development of enzyme replacement therapy for Fabry disease","volume":"85","author":"Tajima","year":"2009","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2012.01.010_bb0080","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1006\/abbi.1994.1144","article-title":"Generation of one set of murine monoclonal antibodies specific for globo-series glycolipids: evidence for differential distribution of the glycolipids in rat small intestine","volume":"310","author":"Kotani","year":"1994","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ymgme.2012.01.010_bb0085","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/jcc.540120314","article-title":"Algorithms for calculating excluded volume and its derivatives as a function of molecular conformation and their use in energy minimization","volume":"12","author":"Kundrot","year":"1991","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ymgme.2012.01.010_bb0090","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/jcc.540160702","article-title":"Accurate modeling of the intramolecular electrostatic energy of proteins","volume":"16","author":"Dudek","year":"1995","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ymgme.2012.01.010_bb0095","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1063\/1.474409","article-title":"Reaction field methods for off-center multipoles","volume":"107","author":"Ponder","year":"1997","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.ymgme.2012.01.010_bb0100","first-page":"9725","article-title":"Analysis and application of potential energy smoothing for global optimization","volume":"B102","author":"Rappu","year":"1998","journal-title":"J. Phys. Chem."},{"key":"10.1016\/j.ymgme.2012.01.010_bb0105","first-page":"5933","article-title":"Polarizable atomic multipole water model for molecular mechanics simulation","volume":"B107","author":"Rew","year":"2003","journal-title":"J. Phys. Chem."},{"key":"10.1016\/j.ymgme.2012.01.010_bb0110","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jmb.2004.01.035","article-title":"The molecular defect leading to Fabry disease: structure of human \u03b1-galactosidase","volume":"337","author":"Garman","year":"2004","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ymgme.2012.01.010_bb0115","first-page":"827","article-title":"A solution for the best rotation to relate two sets of vectors","volume":"A32","author":"Kabsch","year":"1976","journal-title":"Acta Crystallogr."},{"key":"10.1016\/j.ymgme.2012.01.010_bb0120","first-page":"922","article-title":"A discussion of the solution for the best rotation to relate two sets of vectors","volume":"A34","author":"Kabsch","year":"1978","journal-title":"Acta Crystallogr."},{"key":"10.1016\/j.ymgme.2012.01.010_bb0125","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s100380200020","article-title":"Molecular and structural studies of the GM2 gangliosidosis 0 variant","volume":"47","author":"Sakuraba","year":"2002","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2012.01.010_bb0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10038-003-0098-z","article-title":"Structural and immunocytochemical studies on \u03b1-N-acetylgalactosaminidase deficiency (Schindler\/Kanzaki disease)","volume":"49","author":"Sakuraba","year":"2004","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2012.01.010_bb0135","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1007\/s10038-008-0316-9","article-title":"Structural characterization of mutant \u03b1-galactosidases causing Fabry disease","volume":"53","author":"Sugawara","year":"2008","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2012.01.010_bb0140","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF00207037","article-title":"Point mutations in the upstream region of the \u03b1-galactosidase A gene exon 6 in an atypical variant of Fabry disease","volume":"89","author":"Ishii","year":"1992","journal-title":"Hum. Genet."},{"key":"10.1016\/j.ymgme.2012.01.010_bb0145","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1042\/BJ20070479","article-title":"Mutant \u03b1-galactosidase A enzymes identified in Fabry disease patients with residual enzyme activity: biochemical characterization and restoration of normal intracellular processing by 1-deoxygalactonojirimycin","volume":"406","author":"Ishii","year":"2007","journal-title":"Biochem. J."},{"key":"10.1016\/j.ymgme.2012.01.010_bb0150","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/humu.10275","article-title":"Fabry disease: characterization of \u03b1-galactosidase A double mutations and the D313Y plasma enzyme pseudodeficiency allele","volume":"22","author":"Yasuda","year":"2003","journal-title":"Hum. Mutat."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719212000145?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719212000145?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:20:59Z","timestamp":1761088859000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719212000145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S1096719212000145"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2012.01.010","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fabry disease: Biochemical, pathological and structural studies of the \u03b1-galactosidase A with E66Q amino acid substitution","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2012.01.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}